Long-term, Open-label Extension Study for Patients With Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen
Long-term, Open-label Extension Study for Patients With Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen
The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).
Inclusion Criteria:
Other inclusion/exclusion criteria apply.
Rochester, New York 14642, United States
Columbus, Ohio 43205, United States
Milwaukee, Wisconsin 53226, United States
Sofia, 1431, Bulgaria